NCT02987218

Brief Summary

Aneurysmal subarachnoid hemorrhage (aSAH) is characterized by the rupture of an intracranial aneurysm and accumulation of blood in the subarachnoid space with 30 to 40% mortality rate. Amongst the survivors 40-50% suffers disability due to cognitive decline.Trends towards early surgery offers challenge to anesthesiologist to provide optimum brain relaxation and simultaneously maintaining stable hemodynamics. Anesthetic agents are administered to conduct smooth neurosurgical procedure. These agents may affect patient's cognitive function postoperatively.Currently most common anesthetic agents used are either intravenous hypnotic agents (propofol) or volatile inhalational agents (isoflurane/sevoflurane/desflurane). Provision of neuroprotection with propofol and volatile inhalational agents has been studied by various authors.Not many studies have been performed in patients undergoing aneurysmal clipping surgeries looking into effects of various anesthetic agents on intraoperative (I/O) brain condition, I/O hemodynamic and POCD.Thus present study is planned to compare propofol and desflurane for long term postoperative cognitive decline in patients undergoing surgery following aneurysmal subarachnoid hemorrhage.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jul 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

November 13, 2016

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 8, 2016

Completed
Last Updated

December 8, 2016

Status Verified

December 1, 2016

Enrollment Period

1.3 years

First QC Date

November 13, 2016

Last Update Submit

December 6, 2016

Conditions

Keywords

POCDsubarachnoid hemorrhagePropofolDesflurane

Outcome Measures

Primary Outcomes (1)

  • Assessment of cognitive function at one month following surgery.

    Montreal Cognitive Assessment scale is used

    One month

Secondary Outcomes (3)

  • Assessment of cognitive function preoperatively Assessment of cognitive function at discharge. Comparison of biomarker of cognitive dysfunction

    Baseline cognition assessment prior to surgery

  • Assessment of cognitive function preoperatively Assessment of cognitive function at the time of discharge from hospital

    Discharge from hospital

  • Comparison of biomarker (S-100B) levels

    Prior to surgery , After clipping of aneurysm, One hour after completion of surgery

Study Arms (2)

PROPOFOL

ACTIVE COMPARATOR

Intravenous hypnotic agent Decrease Cerebral Metabolic reduction Decrease ICP(Intracranial pressure) Better cognitive Function preservation

Drug: Propofol

DESFLURANE

ACTIVE COMPARATOR

Inhalational agent. Decreases cerebral metabolism Increase /decreases ICP Cognition preservation

Drug: Desflurane

Interventions

Intravenous hypnotic agent Decrease Cerebral Metabolic reduction Decrease ICP Better cognitive Function preservation

PROPOFOL

Inhalational agent. Decreases cerebral metabolism Increase /decreases ICP Cognition preservation

DESFLURANE

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for aneurysmal SAH surgery with clinical and radiological evidence of cerebral aneurysm.
  • Age between 18 to 65 yrs.
  • World Federation of neurosurgery grade 1, 2.
  • American society of Anesthesia grade 1, 2 and 3.

You may not qualify if:

  • Co-morbidities other than hypertension and diabetes mellitus like cardiovascular disease and respiratory impairment.
  • Patients with known psychiatric disease.
  • History of drug abuse.
  • Low level of education (illiterate) or multiple failures in school.
  • Patients who are unconscious, intubated or tracheostomised even after two weeks following exposure to anesthesia will also be excluded from the study.
  • Intraoperative complications like massive blood loss, prolonged clipping time(\>20minutes), severe intraoperative brain swelling precluding replacement of bone flap.
  • Patients with infectious diseases and respiratory complications.
  • Multiple surgeries.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Postgraduate institute of medical education and research

Chandigarh, Chandigarh, 160012, India

Location

Related Publications (1)

  • Wong GK, Lam S, Ngai K, Wong A, Mok V, Poon WS; Cognitive Dysfunction after Aneurysmal Subarachnoid Haemorrhage Investigators. Evaluation of cognitive impairment by the Montreal cognitive assessment in patients with aneurysmal subarachnoid haemorrhage: prevalence, risk factors and correlations with 3 month outcomes. J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1112-7. doi: 10.1136/jnnp-2012-302217. Epub 2012 Jul 31.

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Interventions

PropofolDesflurane

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsEthyl EthersEthersMethyl EthersHydrocarbons, FluorinatedHydrocarbons, Halogenated

Study Officials

  • Shalvi Mahajan, MD

    Post Graduate Institute of Medical Education and Research, Chandigarh

    PRINCIPAL INVESTIGATOR
  • Hemant Bhagat, DM

    Post Graduate Institute of Medical Education and Research, Chandigarh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Resident

Study Record Dates

First Submitted

November 13, 2016

First Posted

December 8, 2016

Study Start

July 1, 2015

Primary Completion

October 1, 2016

Study Completion

November 1, 2016

Last Updated

December 8, 2016

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will share

Locations